Next Article in Journal
Mitochondrial DNA: Hotspot for Potential Gene Modifiers Regulating Hypertrophic Cardiomyopathy
Next Article in Special Issue
The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study
Previous Article in Journal
Brain Stimulation in Eating Disorders: State of the Art and Future Perspectives
Previous Article in Special Issue
Thiopurines’ Metabolites and Drug Toxicity: A Meta-Analysis
Open AccessReview

Adaptive Designs: Lessons for Inflammatory Bowel Disease Trials

1
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20090 Milan, Italy
2
Department of Gastroenterology and Inserm NGERE U1256, Nancy University Hospital, University of Lorraine, 54500 Vandoeuvre-lès-Nancy, France
3
Department of Gastroenterology, Humanitas Clinical and Research Center-IRCCS, Rozzano, 20089 Milan, Italy
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(8), 2350; https://doi.org/10.3390/jcm9082350
Received: 22 June 2020 / Revised: 10 July 2020 / Accepted: 22 July 2020 / Published: 23 July 2020
(This article belongs to the Special Issue Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD))
In recent decades, scientific research has considerably evolved in the field of inflammatory bowel diseases (IBD) and clinical studies have become increasingly complex, including new outcomes, different study populations, and additional techniques of re-randomization and centralized control. In this context, randomized clinical trials are the gold standard for new drugs’ development. However, traditional study designs are time-consuming, expensive, and only a small percentage of the tested therapies are approved. For this reason, a new study design called “adaptive design” has been introduced, allowing to accumulate data during the study and to make predefined adjustments based on the results of scheduled interim analysis. Our aim is to clarify the advantages and drawbacks of adaptive designs in order to properly interpret study results and to identify their role in upcoming IBD trials. View Full-Text
Keywords: adaptive designs; study design; inflammatory bowel disease adaptive designs; study design; inflammatory bowel disease
Show Figures

Figure 1

MDPI and ACS Style

D'Amico, F.; Danese, S.; Peyrin-Biroulet, L. Adaptive Designs: Lessons for Inflammatory Bowel Disease Trials. J. Clin. Med. 2020, 9, 2350. https://doi.org/10.3390/jcm9082350

AMA Style

D'Amico F, Danese S, Peyrin-Biroulet L. Adaptive Designs: Lessons for Inflammatory Bowel Disease Trials. Journal of Clinical Medicine. 2020; 9(8):2350. https://doi.org/10.3390/jcm9082350

Chicago/Turabian Style

D'Amico, Ferdinando; Danese, Silvio; Peyrin-Biroulet, Laurent. 2020. "Adaptive Designs: Lessons for Inflammatory Bowel Disease Trials" J. Clin. Med. 9, no. 8: 2350. https://doi.org/10.3390/jcm9082350

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop